The conference will feature three parallel tracks specifically developed for researchers and drug and device companies, patient advocates and patient organizations, and investors.(PRWeb September 15, 2011)Read the full story at http://www.prweb.com/...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to DIA and NORD Host First Conference to Address All Aspects of Orphan…
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account